Proviraplex 25 mg

Proviraplex 25 mg by Axiolabs – Mesterolone Oral Androgen

Proviraplex 25 mg is a pharmaceutical-grade preparation of Mesterolone, manufactured by Axiolabs. It's a synthetic androgen and derivative of dihydrotestosterone (DHT) commonly used for boosting testosterone function and restoring hormonal balance during or after anabolic steroid cycles.

This oral androgen is especially popular for its ability to improve libido, enhance muscle hardness, and offset estrogenic effects—without converting to estrogen itself. Athletes and bodybuilders often turn to Proviraplex to maintain strength and appearance during cutting phases.

Mechanism and Benefits

Mesterolone binds strongly to androgen receptors but does not aromatize. This makes it a valuable addition to post-cycle therapy (PCT) or even mid-cycle for reducing estrogenic side effects like water retention and gynecomastia. Additionally, it has been explored for its role in treating male infertility and hypogonadism [PubMed Study].

• Improves androgenic activity without raising estrogen
• Enhances libido and mental focus
• Promotes muscle density and vascular appearance
• Supports natural testosterone production post-cycle
• No liver toxicity at therapeutic doses

Cycle and Stacking Tips

Proviraplex is often used during cutting cycles alongside compounds like Haloplex or Oxandroplex for a dry, lean look. It's also an effective synergy partner with Testaplex-E 250 to maintain free testosterone levels and reduce SHBG binding.

Example Proviraplex cycle (6 weeks):

• Weeks 1–6: 50 mg/day split AM and PM
• Stack with: 300–500 mg/week Testosterone Enanthate

Proviraplex is also a great addition during PCT to enhance mood and libido. It stacks well with Clomiplex or Tamoxiplex for effective recovery.

Why Choose This Axiolabs Product?

As part of the high-quality Mesterolone lineup, this formulation stands out for its reliable dose accuracy and consistent effects. Many users of Axiolabs Proviraplex praise its ability to sharpen physique and enhance well-being without suppressing the HPTA axis significantly.

Frequently Asked Questions